March 27, 2024 · Form 4 insider transaction
Brennan Christine bought 26,438 shares of Boundless Bio, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The stock option vests in 36 substantially equal monthly installments beginning on April 27, 2024.